Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
07/2003
07/03/2003WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003018548A3 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
07/03/2003WO2002079189A3 Spiroisoquinoline compounds, methods for their preparation and intermediates
07/03/2003US20030125561 Triazole or imidazole oxide compound with a positively charged electron withdrawing group (a quaternary nitrogen containing amidine or imine group); useful in effecting the acylation step in amide formation (peptide synthesis)
07/03/2003US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound
07/03/2003US20030125341 Pyrazolopyrimidines as crf receptor antagonists
07/03/2003US20030125333 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
07/03/2003US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003CA2471083A1 Benzhydryl derivatives
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1323420A1 Remedies for inflammatory bowel diseases
07/02/2003EP1323419A1 Airway mucus secretion inhibitors
07/02/2003EP1323160A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer
07/02/2003EP1323120A1 Fluoroscopic registration artifact with optical and/or magnetic markers
07/02/2003EP1322653A2 Metal complexes for use in medical and therapeutic applications
07/02/2003EP1322651A1 Bicyclic heteroaromatic compounds
07/02/2003EP1322650A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
07/02/2003EP1322649A2 Process for the preparation of 2-alkoxy-6-trifluoromethyl-n-([1,2,4]triazolo[1,5-c]pyrimidin-2-yl)benzenesulfonamides
07/02/2003EP1322636A1 Farnesyl transferase inhibiting 6- (substituted phenyl)methyl]-quinoline and quinazoline derivatives
07/02/2003EP1322613A1 Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
07/02/2003EP1322611A1 Chemical compounds
07/02/2003EP1322598A1 Nitroso diphenylamine derivatives
07/02/2003EP1322340A2 Manganese complexes for magnetic resonance imaging
07/02/2003EP1045849B1 Purine derivatives having phosphodiesterase iv inhibition activity
07/02/2003EP1023399B1 Novel methods of syntheses of phthalocyanine compounds
07/02/2003EP0968983B1 Hexanitrohexaazaisowurtzitane composition and explosive composition containing said composition
07/02/2003EP0945454B1 Iminochlorinaspartic acid derivatives
07/02/2003CN1427827A 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
07/02/2003CN1113059C Pipeazino derivatives as neurokinin antagonists
07/01/2003US6586434 Method for the preparation of tetrahydrobenzothiepines
07/01/2003US6586430 Administering azabicyclo compounds to treat human immunodeficiency virus infections and respiratory system disorders
07/01/2003US6586429 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders
07/01/2003US6586421 For therapy of central nervous system, including diseases, disorders, and conditions related to, such as anxiety, depression, hypertension, migraine, obesity, compulsive disorders, schizophrenia, autism, neurodegenerative disorders
07/01/2003US6586418 Heteroaryl-phenyl substituted compounds that are inhibitors of trypsin-like serine protease enzymes; anticoagulant for treatment and prevention of thromboembolic disorders
06/2003
06/26/2003WO2003051887A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
06/26/2003WO2003051886A1 Pyrazolopyridazine derivatives
06/26/2003WO2003051885A1 Nitrogen-containing heterocyclic compounds and use thereof
06/26/2003WO2003051884A1 Fused indole compound, process for producing the same, and use
06/26/2003WO2003051883A1 Indole derivative
06/26/2003WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
06/26/2003WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003WO2003051840A1 Pyrrolidine and piperidine derivates as nk1 antagonists
06/26/2003WO2003051795A2 Resin-bonded isonitriles
06/26/2003WO2003051346A2 Use of selective pde5 inhibitors for treating partial and global respiratory failure
06/26/2003WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
06/26/2003US20030120105 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
06/26/2003US20030120072 Such as (4-(3,4-Difluoro-phenyl)-piperazin-1-yl)-((4S ,4aS,8aR)-2-((S)-3-(6-methoxy-pyridin-3-yl)-2-methyl-propyl)-decahydro -isoquinolin-4yl)-methanone for treatment of schizophrenia, depression, anxiety and bipolar disorders
06/26/2003US20030120069 1,1'-((Propane-1,3-diyl)dioxy)bis((11aS)-7-methoxy-2 -methy lidene-1,2,3,11-tetrahydro-5H-pyrrolo(2,1-c)(1,4)benzodiazep in-5-one) derivatives; viricides, parasiticide, bactericides, gene therapy and treating cisplatin refractory disease
06/26/2003US20030120066 Synthetic peptides
06/26/2003US20030119887 Lactacystin analogs
06/26/2003US20030119864 Farnesyl transferase inhibitors
06/26/2003US20030119856 Thiazole compounds useful as inhibitors of protein kinase
06/26/2003US20030119848 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance
06/26/2003US20030119843 Tricycloheteroaromic ring containing imidazole compounds used as farnesyl transferase and geranylgeranyl transferase inhibitor
06/26/2003US20030119842 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines
06/26/2003US20030119841 Treatment and prevention of anxiety and convulsive disorders
06/26/2003US20030119823 5-(1,1-dioxido-1,2-thiazinan-2-yl)-n-(4-fluorobenzyl)-8-hydrox y-1,6-naphthyridine-7-carboxamide; preventing or treating hiv or aids
06/26/2003US20030119822 Bridged bicyclic amino acid-derived [1,4]benzodiazepine vasopressin receptor antagonists
06/26/2003US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke.
06/26/2003US20030118937 Optical information recording medium
06/26/2003US20030118877 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470210A1 Use of selective pde5 inhibitors for treating partial and global respiratory failure
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003CA2467780A1 N-carbacycle monosubstituted indolocarbazoles as protein kinase inhibitors
06/25/2003EP1321467A2 High affinity inhibitors for target validation and uses thereof
06/25/2003EP1320532A1 Tetrapyrroles
06/25/2003EP1320531A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/25/2003EP1320528A2 Substituted phthalides as anti-convulsive drugs
06/25/2003EP1320383A2 Photosensitisers
06/25/2003EP1320366A1 Substituted piperidines as melanocortin receptor agonists
06/25/2003EP1200439B1 1,2-dihydro-1-oxo-parazino(1,2-a) indole derivatives
06/25/2003EP1098896B1 5-bicycloindole compounds
06/25/2003EP0641343B1 4-mercaptoacetylamino-[2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
06/25/2003CN1426413A Imidazopyridine derivatives
06/25/2003CN1112110C Process for extracting high purity tea polyphenol, tea pigment and tea caffeine from tea
06/24/2003US6583182 Atomic numbers 21-30 are components of enzymes required for nucleic acid replication; substituted polyaza compounds inhibit cell replication by decreaseing bioavailability of iron or copper
06/24/2003US6583154 Compounds and methods which modulate feeding behavior and related diseases
06/24/2003US6583147 Pyrazolopyrimidinone derivatives for the treatment of impotence
06/24/2003US6583143 CRF receptor antagonists and methods relating thereto
06/24/2003US6583141 T cell mediated rheumatic diseases
06/24/2003US6583135 Substituted azepino[4,5b]indole derivatives
06/24/2003US6583134 Aza- indolyl derivatives for treating obesity
06/24/2003US6583132 Oxidant scavengers
06/24/2003US6582930 Porphyrin for use as diagnostic tools in the food industry and pollution control
06/24/2003CA2288910C Pyrazolopyrimidinones for sexual dysfunction
06/24/2003CA2066094C Fused heterocyclic compounds, their production and use
06/19/2003WO2003050082A2 Regioisomerically pure oxochlorins and methods of synthesis
06/19/2003WO2003049741A1 Ureas of 2-aminobenzothiazoles as adenosine modulators
06/19/2003WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors
06/19/2003WO2003049731A1 Process for affecting neurologic progression
06/19/2003WO2003049679A2 Mitotic kinesin inhibitors
06/19/2003WO2003049678A2 Mitotic kinesin inhibitors
06/19/2003WO2003049527A2 Mitotic kinesin inhibitors
06/19/2003WO2000077000A9 New bispidine compounds useful in the treatment of cardiac arrhythmias
06/19/2003US20030114674 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
1 ... 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 ... 573